Grafa News and Videos — Page 153

T. Rowe Price Group (NASDAQ:TROW) reported preliminary assets under management of $1,863 billion as of September 30, 2026, compared with $1,897 billion on August 31 and $1,893 billion on June 30.

Mirum Pharmaceuticals (NASDAQ:MIRM) announced topline results from the Phase 3 EXPAND study evaluating LIVMARLI (maralixibat) in patients aged 6 months and older with ultra-rare cholestatic liver diseases, including biliary atresia.

IonQ (NYSE:IONQ) announced a definitive agreement to acquire Elisity, Inc., a Zero Trust security company, in an all-stock transaction valued at up to $1.3 billion, including a potential $150 million earnout.

X-Bow Systems announced that it was selected by Leidos (NYSE:LDOS) to develop and manufacture solid rocket motor booster systems for the U.S. Army’s Low-Cost Containerized Munition (LCCM) program.

Dot Ai (NASDAQ:DAIC) completed the acquisition of Envoy Technologies from BladeRanger through an all-stock transaction valued at approximately $65 million, using common stock and Series C Convertible Preferred Stock based on an agreed $6 reference price.

Flyte Aviation (NASDAQ:VJET) reported preliminary third-quarter 2026 revenue of approximately $2.15 million, compared with $1.02 million in the second quarter of 2026.

Enovix (NASDAQ:ENVX) reported preliminary Q3 2026 revenue of approximately $11 million, compared with company guidance of $9 million to $10 million, while revenue increased from the prior-year period.

Bristol Myers Squibb (NYSE:BMY) announced topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ101 (225Ac-DOTATATE) in patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

First Tracks Biotherapeutics (NASDAQ:TRAX) reported Phase 1b results for ANB033, showing statistically significant changes in intestinal damage and immune-cell measurements during a gluten-challenge study in patients with celiac disease.

Kratos Defense & Security Solutions (NASDAQ:KTOS) and Airbus completed the first European test flight of the U740-Valkyrie uncrewed combat aircraft, with the flight meeting planned objectives including autonomous flight operations and mission adjustments.